Comparative analysis of HPLC profile of cytosolic thymidine kinase activity between hepatoma and regenerating liver in rat with reference to phosphorylation.
Thymidine kinase (TK) activity in rat hepatoma JB1 and AH136B was mainly due to cytosolic TK and was much higher than that in rat regenerating liver. Two forms of cytosolic TK, designated as TK-I and TK-II, were revealed in addition to mitochondrial TK in anion-exchange high performance liquid chromatography (HPLC) of the enzyme extract from hepatoma JB1. During incubation of the enzyme extract at 20 degrees C in the presence of phosphatase inhibitor NaF, TK-II activity remained while TK-I activity almost disappeared. Thus, TK-II appeared to be more stable than TK-I. In Western blot analysis, TK-II was much more phosphorylated and exhibiting higher specific activity than TK-I. Meanwhile, regenerating liver derived from the rat 24 h after partial hepatectomy showed only TK-I activity, which completely disappeared after incubation at 20 degrees C even in the presence of NaF. Consequently, the presence of TK-II might account for the higher TK activity in hepatomas than in regenerating liver.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Affiliations: Department of Biochemistry, Chiba University School of Medicine, Chuo-ku, Chiba 260-8670, Japan.
Publication date: January 1, 1999
More about this publication?
- The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites